SCHEMBL6556596

SCHEMBL6556596

O=C(Nc1ccc(F)c(Br)c1)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
IDO1 P14902 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
NPY5R Q15761 3/20 0.44
MAPT P10636 1/20 0.44
EPHX2 P34913 1/20 0.44
HDAC1 Q13547 4/20 0.43
HDAC7 Q8WUI4 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC6 Q9UBN7 3/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535627 0.86 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL6557195 0.86 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL8903304 0.86 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL14716053 0.85 L3MBTL1 (0.58) L3MBTL1CA12CA1CA2CA9
SCHEMBL31146306 0.84 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL6602968 0.84 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL4117988 0.80 IDO1 (0.48) IDO1SMN1; SMN2GAAMAPT
SCHEMBL8530877 0.79 AR (0.58) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL8361373 0.79 CYP1A2 (0.51) CYP1A2CYP2C9CYP2C19L3MBTL1CA12
SCHEMBL6540259 0.79 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19L3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1186328-C Substd. 5-benzyl-2,4-diaminopyrimidines BASLIDE PHARMA AG (CH) 2005-01-26 CN disclosed
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
CN-1387516-A Substd. 5-benzyl-2,4-diaminopyrimidines BASLIDE PHARMA AG (CH) 2002-12-25 CN disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed